Two Sigma Advisers
FLNA

Two Sigma Advisers’s Filana Therapeutics FLNA Stock Holding History

Two Sigma Advisers’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-954,800
Closed -$1.89M – 1754
2025
Q4 		$1.89M Sell
954,800
-6,700
-0.7% -$21.5K ﹤0.01% 1211
2025
Q3 		$2.8M Sell
961,500
-22,100
-2% -$50.8K 0.01% 980
2025
Q2 		$1.78M Buy
983,600
+75,000
+8% +$133K ﹤0.01% 1184
2025
Q1 		$1.36M Buy
908,600
+301,900
+50% +$762K ﹤0.01% 1322
2024
Q4 		$1.43M Buy
+606,700
New +$10.7M ﹤0.01% 1286
2020
Q1 		– Sell
-39,075
Closed -$203K – 2562
2019
Q4 		$203K Buy
+39,075
New +$67.5K ﹤0.01% 2186
2015
Q3 		– Sell
-1,906
Closed -$23K – 1954
2015
Q2 		$23K Buy
1,906
+14
+0.7% +$192 ﹤0.01% 1851
2015
Q1 		$25K Sell
1,892
-85
-4% -$1.15K ﹤0.01% 1833
2014
Q4 		$28K Buy
+1,977
New +$34.2K ﹤0.01% 2380
2014
Q3 		– Sell
-3,692
Closed -$149K – 2618
2014
Q2 		$149K Buy
3,692
+1,586
+75% +$58.7K ﹤0.01% 2323
2014
Q1 		$82K Buy
+2,106
New +$74.3K ﹤0.01% 2185

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Two Sigma Advisers's FLNA Position: Q1 2026 in Review

Two Sigma Advisers sold out of Filana Therapeutics (FLNA) in Q1 2026, closing a stake of 954,800 shares — an estimated $1.89M sold.

Two Sigma Advisers first reported a position in FLNA in Q1 2014 and held it in 11 quarters. The position peaked at $2.8M in Q3 2025. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Two Sigma Advisers reported no remaining Filana Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 954,800 Filana Therapeutics shares in Q1 2026, an estimated $1.89M.
  • Two Sigma Advisers first reported a position in Filana Therapeutics in Q1 2014 and held it in 11 quarters.
  • Two Sigma Advisers's Filana Therapeutics position peaked at $2.8M in Q3 2025.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.